Vyome Holdings, Inc. (HIND) Financial Analysis & Valuation | Quarter Chart
Vyome Holdings, Inc. (HIND)
HINDPrice: $2.37
Fair Value: 🔒
🔒score
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting im... more
Description
Shares
| Market Cap | $13.38M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | US | CEO | Venkateswarlu Nelabhotla |
| IPO Date | 2016-10-06 | CAGR | — |
| Employees | 18 | Website | www.vyometx.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
HIND chart loading...
Fundamentals
Technicals
| Enterprise Value | $-119.19M | P/E Ratio | -11.29 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-0.21 | EPS Growth 1Y | -87.72% |
| EPS Growth 3Y | -99.98% | EPS Growth 5Y | -99.99% |
| Revenue Growth 1Y | -48.74% | Gross Margin | 0.62% |
| Operating Margin | -3.48% | Profit Margin | -2.74% |
| ROE | -4.93% | ROA | -1.63% |
| ROCE | -3.71% | Current Ratio | 1.94 |
| Quick Ratio | 1.94 | Cash Ratio | 1.83 |
| Debt/Equity | 0.02 | Interest Coverage | -450.2 |
| Altman Z Score | -19.9 | Piotroski Score | 3 |